Genetic Engineering NewsViroPharma to buy Swedish firm DuoCortBizjournals.comThe company said, “Patients with adrenal insufficiency are dependent on exogenous glucocorticoid replacement therapy, such as hydrocortisone. While standard formulations of …
Eastern Iowa transplant features rare swap among identical twins – Radio Iowa
Eastern Iowa transplant features rare swap among identical twinsRadio IowaTwin brothers from eastern Iowa are recovering from a rare kidney transplant surgery. Doctors at the University of Iowa Hospitals and Clinics say it's the first “perfect ma…
CardioMEMS, Inc. Presented the Phoenix 2011 Most Promising New Product Award – PR Newswire (press release)
CardioMEMS, Inc. Presented the Phoenix 2011 Most Promising New Product AwardPR Newswire (press release)"We believe the CardioMEMS Heart Failure Monitoring System will prove be to a significant step forward in the management of heart failure patien…
Dynavax reports late stage drug trial, Q3 losses widen – Proactive Investors USA & Canada
Proactive Investors USA & CanadaDynavax reports late stage drug trial, Q3 losses widenProactive Investors USA & CanadaThe phase three study, which enrolled 507 patients aged 18 to 75 with chronic kidney disease, had been conducted at 69 sites in the US…
ViroPharma Will Buy DuoCort for $33.6M Up Front if EU-Filed Hydrocortisone … – Genetic Engineering News
Genetic Engineering NewsViroPharma Will Buy DuoCort for $33.6M Up Front if EU-Filed Hydrocortisone …Genetic Engineering NewsThe EC's Committee for Medicinal Products for Human Use (CHMP) adopted a positive on the modified release hydrocortisone t…
Public Unaware of Safe Blood Donation Efforts – Middle East North Africa Financial Network
Public Unaware of Safe Blood Donation EffortsMiddle East North Africa Financial Network"There are people who don't donate blood because they don't have enough and accurate knowledge on blood donation. Others are worried that if they donate…
Biotech Investing Lessons Learned: Diversify, Be Patient – Seeking Alpha
Proactive Investors USA & CanadaBiotech Investing Lessons Learned: Diversify, Be PatientSeeking AlphaIn Biogen's case, results are for daclizumab for multiple sclerosis and for BG-12 for MS as well. Onyx's results are for regorafenib for metast…
Selecta Announces $47.25 Million Financing to Broaden R&D Capabilities and … – MarketWatch (press release)
Selecta Announces $47.25 Million Financing to Broaden R&D Capabilities and …MarketWatch (press release)Examples for applications include autoimmune diseases, allergies and transplant rejection. Selecta's pipeline currently contains a vaccine …
Rituximab – A Cancer Drug – May Treat Sufferers Of Chronic Fatigue Syndrome – Authority Empire
Authority EmpireRituximab – A Cancer Drug – May Treat Sufferers Of Chronic Fatigue SyndromeAuthority EmpireNorway researchers report that they can treat Chronic Fatigue Syndrome with the cancer treatment drug Rituximab (Rituxan), which is a biologi…
Double Hand Transplant Patient Heads Home – WCVB-TV
Double Hand Transplant Patient Heads HomeWCVB-TVJust three weeks ago, he had double hand transplant surgery at Brigham and Women's Hospital. Now he's been able to return home. Doctors said each day he's improving. His fingernails are growin…